arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

ACADIA Pharmaceuticals Inc.

ACAD Health Care Biotechnology: Pharmaceutical Preparations
$28.02
Today
as of Sep 4, 16:45 ET
Last 30 days +7.73% Jul 28 → Sep 04
$25.21 $26.65 $28.09 $29.53 $30.97 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$27.77
High
$28.19
Low
$27.65
Volume
$2M
Avg Vol
$2M
Mkt Cap
$4.9B
P/E (TTM)
45.19
Beta
52w High
$30.96
52w Low
$19.69
Div Yield
Shares Out
$172M

Recent Press Releases & News last 60 days · 25 items

▸ Show all 25 press releases & news Free account →

Overview

52-week range
$20
$31
74% of range
Avg surprise (last 3)
-8.6%
Avg reaction (last 2)
-1.0%
50% positive
Latest IV / EM
82%
EM ±12.8% · $28 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.40$-0.20$0.01$0.21$0.42 Actual $-0.27Actual $0.01Actual $-0.40Actual $0.10Actual $0.20Actual $0.20Actual $0.11Est $0.10Actual $0.16Est $0.14Actual $0.42Actual $0.02Est $0.04Actual $0.18 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$0$81M$162M$243M$323M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.18 financials
Wed May 6, 2026Mar/2026 $0.02 $0.04 -50.0% -81.8% -3.9% earnings
Tue Sep 30, 2025Sep 2025 $0.42 financials
Wed Aug 6, 2025Jun/2025 $0.16 $0.14 +14.3% earnings
Wed May 7, 2025Mar/2025 $0.11 $0.10 +10.0% +1.9% earnings
Mon Sep 30, 2024Sep 2024 $0.20 financials
Sun Jun 30, 2024Jun 2024 $0.20 financials
Sun Mar 31, 2024Mar 2024 $0.10 financials
Sat Sep 30, 2023Sep 2023 $-0.40 financials
Fri Jun 30, 2023Jun 2023 $0.01 financials
Fri Mar 31, 2023Mar 2023 $-0.27 financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$308M$268M$279M$265M$244M$250M
Cost of revenue$28M$25M$22M$21M$20M$19M
Gross profit
Operating income$38M$-5M$36M$32M$19M$32M
Net income$32M$4M$72M$27M$19M$33M
EPS (diluted)$0.18$0.02$0.42$0.16$0.11$0.20

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$385M$282M$178M$258M$254M$218M$320M$155M
Inventory$109M$112M$111M$106M$111M$103M$92M$87M
Total current assets$1.22B$1.10B$1.06B$1.08B$961M$871M$938M$788M
Total assets$1.74B$1.61B$1.56B$1.33B$1.23B$1.13B$1.19B$977M
Long-term debt
Total liabilities$436M$357M$337M$413M$403M$367M$455M$400M
Total equity$1.31B$1.25B$1.23B$917M$822M$765M$733M$577M

Implied volatility — last 90 days

32%53%73%94%115% Jun 07 — IV 62% · EM ±8.6%Jun 08 — IV 44% · EM ±5.9%Jun 09 — IV 46% · EM ±5.7%Jun 10 — IV 39% · EM ±4.6%Jun 11 — IV 112% · EM ±12.4%Jun 15 — IV 55% · EM ±4.0%Jun 19 — IV 59% · EM ±13.1%Jun 22 — IV 35% · EM ±7.2%Jun 23 — IV 68% · EM ±13.9%Jun 24 — IV 40% · EM ±7.9%Jun 25 — IV 40% · EM ±7.8%Jun 26 — IV 71% · EM ±13.6%Jun 29 — IV 47% · EM ±8.3%Jun 30 — IV 32% · EM ±5.5%Jul 02 — IV 38% · EM ±6.2%Jul 03 — IV 39% · EM ±6.2%Jul 06 — IV 49% · EM ±6.8%Jul 08 — IV 38% · EM ±4.8%Jul 09 — IV 66% · EM ±7.8%Jul 10 — IV 81% · EM ±9.0%Jul 13 — IV 110% · EM ±9.2%Jul 15 — IV 62% · EM ±3.7%Jul 20 — IV 51% · EM ±12.2%Jul 21 — IV 60% · EM ±14.0%Jul 22 — IV 67% · EM ±15.4%Jul 23 — IV 47% · EM ±10.6%Jul 24 — IV 47% · EM ±10.4%Jul 27 — IV 60% · EM ±12.6%Jul 28 — IV 52% · EM ±10.6%Jul 29 — IV 65% · EM ±13.0%Jul 30 — IV 51% · EM ±10.0%Jul 31 — IV 55% · EM ±10.4%Aug 03 — IV 40% · EM ±7.1%Aug 04 — IV 67% · EM ±11.6%Aug 05 — IV 35% · EM ±5.9%Aug 06 — IV 39% · EM ±6.3%Aug 07 — IV 42% · EM ±6.5%Aug 10 — IV 60% · EM ±8.3%Aug 12 — IV 47% · EM ±5.9%Aug 13 — IV 47% · EM ±5.5%Aug 17 — IV 59% · EM ±4.9%Aug 18 — IV 73% · EM ±5.3%Aug 19 — IV 76% · EM ±4.5%Aug 20 — IV 106% · EM ±4.4%Aug 24 — IV 66% · EM ±13.8%Aug 25 — IV 57% · EM ±11.7%Aug 26 — IV 65% · EM ±12.9%Aug 27 — IV 65% · EM ±12.8%Aug 28 — IV 65% · EM ±12.5%Aug 31 — IV 69% · EM ±12.2%Sep 01 — IV 73% · EM ±12.6%Sep 02 — IV 78% · EM ±13.0%Sep 03 — IV 116% · EM ±18.7%Sep 04 — IV 82% · EM ±12.8%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.